By Yafo Life Science
September 18th, 2021 (Shanghai) — We are glad to announce that Xiaoyan Zhong, Vice President of Sinotau, has been invited to showcase at ACCESS CHINA Biotech Forum on Thursday, September 23, 2021 at 9:00 p.m. ET. ACCESS CHINA Biotech Forum is the largest online corporate access event between China and the western biopharma industry.
If you are interested in listening to the live event, please register at https://biotochina.org/register/
Sinotau Pharmaceutical Group was founded in 2005, after 14 years of development, it has transformed from a company that mainly develops, introduces and sells generic drugs to an innovative radiopharmaceutical company with the most comprehensive pipelines in China. Sinotau has more than 10 products under development in cardiology, neurology and oncology fields, combining generic and innovative drugs, with a comprehensive layout of short, medium and long-term fronts.
About ACCESS CHINA
ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations. View more information at https://biotochina.org/access-china-forum/
ACCESS CHINA Upcoming event
“ACCESS CHINA Biotech Forum @ The 16th China Pharma & MedTech BD Forum” will be held in Suzhou and online on September 23rd-30th, 2021. This conference is the largest ACCESS CHINA event of the year.
Register ACCESS CHINA online, please visit:
For more information, please contact: